ASC Theraputics Revenue and Competitors
Estimated Revenue & Valuation
- ASC Theraputics's estimated annual revenue is currently $4.3M per year.
- ASC Theraputics's estimated revenue per employee is $155,000
Employee Data
- ASC Theraputics has 28 Employees.
- ASC Theraputics grew their employee count by -10% last year.
ASC Theraputics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Gene and Cell Therapy | Reveal Email/Phone |
2 | SVP, Global Operations | Reveal Email/Phone |
3 | VP, Global Regulatory Affairs | Reveal Email/Phone |
4 | Scientist and Senior Lab Manager | Reveal Email/Phone |
5 | Executive Assistant and HR Manager | Reveal Email/Phone |
6 | Senior Scientist | Reveal Email/Phone |
7 | Research Associate | Reveal Email/Phone |
ASC Theraputics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is ASC Theraputics?
ASC Therapeutics focuses on the development of curative therapies for rare diseases. Our gene, CRISPR and cell therapies were developed at Applied StemCell, a life sciences company for over 12 years, including proprietary gene editing technologies. Our development pipeline includes several preclinical stage projects focusing on monogenic blood disorders that exhibit a high genetic penetrance and conditions requiring immunomodulatory interventions. Contact us for partnership opportunities. #therapeutics #CRISPR #celltherapy #genetherapy #blooddisorders #hemophilia www.asctherapeutics.com
keywords:N/A
N/A
Total Funding
28
Number of Employees
$4.3M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ASC Theraputics News
Most recently, ASC Therapeutics received Fast Track Designation from the U.S. Food and Drug Administration for its therapy for hemophilia A,...
ASC Therapeutics is a biopharmaceutical company pioneering the development of gene replacement therapies, in-vivo gene editing and allogeneic...
... include Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, ... Essential Hemophilia A Pipeline therapies such as SPK-8011,...
Other Companies in Milpitas
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.4M | 28 | -10% | N/A |
#2 | $5.3M | 28 | 12% | N/A |
#3 | $6.5M | 28 | -10% | N/A |
#4 | $4.8M | 28 | 12% | N/A |
#5 | $4.3M | 28 | -18% | N/A |